Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (1175)	11/2/1999 8:01:00 PM
From: Beltropolis Boy	Read Replies (1) \| Respond to of 1686

*slightly OT* thank you, PB -- this is such an excellent link i had to put it here too: recap.com

To: Pseudo Biologist who wrote (1175)	11/2/1999 10:51:00 PM
From: software salesperson	Read Replies (1) \| Respond to of 1686

pb, july/august 1999 national psoriasis bulletin lists 31 projects in pre-clinic/clinic.unfortunately, it is NOT online at www.psoriasis.org hardcopy bulletin lists drug name, company,description,phase. anyway, here goes by company(sorted alpha by drug name): abgenix biogen axys biocryst roche cellcept osi/pfizer immunex genentech/xoma icos idec imnr isis schering maxacalcitol medi connectics ligand ontak allergan angiotech ligand panretin aeterna corixa centocor genetics institute novartis pdli smart anti-cd3 penederm ligand targretin schering tenovil qlti vrtx roche/pdli zenapax sales